Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...

Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

She’s racing to a run-through for a 14-course tasting menu she will barely nibble at as she raves about her weight loss on ...

Thankfully, Walmart has been knocking down prices on at-home fitness gear all month to help you get your reps in without ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Losing weight isn’t as easy as taking a few magical pills. However, certain vitamins and minerals can help ensure your body is functioning as efficiently as possible for weight loss. A well ...

Walmart has an impressive weight set that can do exactly that, and this bestseller is available at a big discount. The BalanceFrom 4-in-1 Adjustable Weight Set is only $65 right now. The regular ...

Wegovy and Ozempic have become household names, but how easy are they to get if you don't meet the medical criteria? Sky's Lucy Marley went to find out.

The outlook cut comes as Eli Lilly competes with Novo Nordisk and other, smaller rivals for share of the exploding weight loss and diabetes drug market. Eli Lilly is developing an obesity pill ...

Eli Lilly expects its experimental weight loss pill, orforglipron, to receive approval as early as next year, CEO David Ricks told Bloomberg Jan. 13. The company is preparing to release key late ...

Separately, Eli Lilly said that it expects its new weight loss pill to be approved by U.S. regulators in 2026. The Indianapolis, Indiana-based company said that it will release late-stage trial ...